RU486 NCCB

Fact Sheet on Mifepristone/Misoprostol Abortion: FDA Rejects Safeguards Used in China, France, Sweden and the United Kingdom Dangers inherent in method evident in precautions used in France: The Food and Drug Administration based its 1996 finding that drug-induced...

FDA CMA Letter

Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD  20852 December 11, 2006 Ref: Docket Number 2006D-0383 Guidance to Industry for Development of Cell-Based Viral Vaccines   To the FDA:   The...